Clinical and Hormonal Effects of Chronic Gonadotropin-Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease

    Kenneth A. Steingold, Dominique de Ziegler, Marcelle I. Cedars … R. Jeffrey Chang
    Studysummary This study found that long-term GnRH agonist administration in premenopausal women with polycystic ovarian disease resulted in persistent suppression of ovarian steroid secretion, while adrenal steroid levels remained unchanged.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Related research 1

    1. Puberty in Boys: Correlation of Plasma Levels of Gonadotropins, Androgens, Estrogens, and Progestins The Journal of Clinical Endocrinology & Metabolism · 1975